Real-world treatment and survival of patients with advanced non-small cell lung Cancer: A German retrospective data analysis

Atezolizumab plus nab-paclitaxel for unresectable, locally advanced or metastatic breast cancer: Real-world results from a single academic center in Austria

10 p | 6 | 4

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: Data from a national registry

8 p | 13 | 3

Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes – an observational cohort study in Sweden

12 p | 6 | 3

Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: A real-world chart review study

11 p | 10 | 2

Real-world evidence of treatment patterns and survival of metastatic gastric cancer patients in Germany

9 p | 1 | 1

Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: Retrospective analysis from Leeds Cancer Centre

12 p | 5 | 1

Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: The IMAGE study

12 p | 9 | 1

Real life patterns of care and progression free survival in metastatic renal cell carcinoma patients: Retrospective analysis of cross-sectional data

7 p | 14 | 1

Checkpoint inhibitors in metastatic gastric and GEJ cancer: A multi-institutional retrospective analysis of real-world data in a Western cohort

10 p | 16 | 0